Sen. Mullin Pushes Bipartisan MVP Act to Only Pay for Medicaid Drugs if They Actually Work
A senate committee must act next: committee consideration.
Companion bill: Rep. Guthrie Introduces MVP Act to Link Medicaid Drug Payments to Patient Outcomes →No action since May 2025
This bill’s path across every version that has carried it.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Smaller pharmaceutical and biotech companies developing expensive gene therapies or specialty drugs could benefit from clearer rules around value-based deals. The anti-kickback safe harbor removes legal uncertainty that has discouraged companies from offering outcome-based refunds to states, making it easier for innovative drug makers to bring products to market with flexible pricing.
Read twice and referred to the Committee on Finance.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
As Congress nears a major overhaul of prescription drug pricing, the bipartisan MVP Act remains a central pillar. The bill aims to modernize Medicaid by allowing states to pay for high-cost gene therapies based on patient outcomes, though critics worry the savings may not reach consumers.
The Medicaid Value-Based Purchasing for Patients (MVP) Act is a top legislative priority for 2025. The bill seeks to codify 'multiple best price' rules, enabling Medicaid programs to enter into outcomes-based agreements for expensive cell and gene therapies without triggering price distortions.
House Democrats are divided over the MVP Act, which expands states' ability to pay for drugs based on patient outcomes. While supporters like Rep. Anna Eshoo argue it increases access to cures for sickle cell disease, others question if it aligns with broader drug pricing reform goals.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
MVP Act
Analysis generated by AI. Always verify with official sources.